Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion type Assertion NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_head.
- NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion description "[MMP-1 and -12 transcript levels were significantly higher in plaques from patients with amaurosis fugax, than in those from asymptomatic patients (P=0.029 and P=0.008 for MMP-1 and MMP-12, respectively), than in those from patients with stroke (P=0.027 and P=0.001, respectively), and than in those from patients with transient ischemic attack (P=0.046 and P=0.008, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_provenance.
- NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion evidence source_evidence_literature NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_provenance.
- NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion SIO_000772 15073384 NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_provenance.
- NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion wasDerivedFrom befree-20140225 NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_provenance.
- NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_assertion wasGeneratedBy ECO_0000203 NP914026.RA2zq_XVyF6ZDS9Bom8D66uOnXUxfx8ZE39t3oHCWReas130_provenance.